Physician profile
Igor D Gregoric
NPI 1043308844
$7,389.37
in general payments reported to CMS, 2019-2025
13 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,429 · 2020: $893 · 2021: $157 · 2022: $433 · 2023: $3,170 · 2024: $993 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,876 · Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,875.80 |
| Food and Beverage | $1,601.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $2,875.80 | 2023 | Organ Care System |
| Abbott Laboratories | $2,443.30 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Agilis Hispro |
| Boston Scientific Corporation | $565.04 | 2019-2024 | |
| Aroa Biosurgery Incorporated | $372.53 | 2024 | |
| Bard Peripheral Vascular, INC. | $285.28 | 2019-2021 | |
| Baxter Healthcare | $282.00 | 2019 | |
| Medtronic Vascular, INC. | $199.71 | 2019 | |
| Wound Management Technologies, INC | $141.89 | 2019 | |
| Medtronic, INC. | $127.58 | 2023 | Swiftset |
| Ethicon US, LLC | $68.61 | 2021-2022 | |
| Heartflow, INC. | $13.95 | 2020 | |
| Lemaitre Vascular, INC. | $13.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Gregoric listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.